Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
Laboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4169399?pdf=render |
id |
doaj-f838f511d27d4ef2ac699692814cb61c |
---|---|
record_format |
Article |
spelling |
doaj-f838f511d27d4ef2ac699692814cb61c2020-11-24T21:58:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10715310.1371/journal.pone.0107153Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.Kelly A CurtisKrystin M AmbroseM Susan KennedyS Michele OwenLaboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample source for HIV surveillance, given the simplified and cost-effective methods of specimen collection, storage, and shipment. Here, we evaluated the use of DBS in conjunction with an in-house multiplex TRI, the HIV-1-specific Bio-Plex assay, which measures direct antibody binding and avidity to multiple HIV-1 analytes. The assay performance was comparable between matched plasma and DBS samples from HIV-1 infected individuals obtained from diverse sources. The coefficients of variation, comparing the median antibody reactivity for each analyte between plasma and DBS, ranged from 2.78% to 9.40% and the correlation coefficients between the two sample types ranged from 0.89 to 0.97, depending on the analyte. The correlation in antibody reactivity between laboratory and site-prepared DBS for each analyte ranged from 0.87 to 0.98 and from 0.90 to 0.97 between site-prepared DBS and plasma. The correlation in assay measures between plasma and DBS indicate that the sample types can be used interchangeably with the Bio-Plex format, without negatively impacting the misclassification rate of the assay.http://europepmc.org/articles/PMC4169399?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kelly A Curtis Krystin M Ambrose M Susan Kennedy S Michele Owen |
spellingShingle |
Kelly A Curtis Krystin M Ambrose M Susan Kennedy S Michele Owen Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. PLoS ONE |
author_facet |
Kelly A Curtis Krystin M Ambrose M Susan Kennedy S Michele Owen |
author_sort |
Kelly A Curtis |
title |
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. |
title_short |
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. |
title_full |
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. |
title_fullStr |
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. |
title_full_unstemmed |
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection. |
title_sort |
evaluation of dried blood spots with a multiplex assay for measuring recent hiv-1 infection. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Laboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample source for HIV surveillance, given the simplified and cost-effective methods of specimen collection, storage, and shipment. Here, we evaluated the use of DBS in conjunction with an in-house multiplex TRI, the HIV-1-specific Bio-Plex assay, which measures direct antibody binding and avidity to multiple HIV-1 analytes. The assay performance was comparable between matched plasma and DBS samples from HIV-1 infected individuals obtained from diverse sources. The coefficients of variation, comparing the median antibody reactivity for each analyte between plasma and DBS, ranged from 2.78% to 9.40% and the correlation coefficients between the two sample types ranged from 0.89 to 0.97, depending on the analyte. The correlation in antibody reactivity between laboratory and site-prepared DBS for each analyte ranged from 0.87 to 0.98 and from 0.90 to 0.97 between site-prepared DBS and plasma. The correlation in assay measures between plasma and DBS indicate that the sample types can be used interchangeably with the Bio-Plex format, without negatively impacting the misclassification rate of the assay. |
url |
http://europepmc.org/articles/PMC4169399?pdf=render |
work_keys_str_mv |
AT kellyacurtis evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection AT krystinmambrose evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection AT msusankennedy evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection AT smicheleowen evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection |
_version_ |
1725851941459722240 |